Menu Search
Equities

QuidelOrtho Corp

QDEL:NSQ

QuidelOrtho Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)40.14
  • Today's Change2.25 / 5.94%
  • Shares traded4.29m
  • 1 Year change-41.84%
  • Beta0.0862
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year QuidelOrtho Corp's revenues fell -8.21% from 3.27bn to 3.00bn. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from a gain of 548.70m to a loss of 10.10m.
Gross margin47.62%
Net profit margin-66.25%
Operating margin-64.61%
Return on assets-24.34%
Return on equity-45.79%
Return on investment-27.75%
More ▼

Cash flow in USDView more

In 2023, cash reserves at QuidelOrtho Corp fell by 174.40m. However, the company earned 280.20m from its operations for a Cash Flow Margin of 9.35%. In addition the company used 187.60m on investing activities and also paid 265.80m in financing cash flows.
Cash flow per share-20.99
Price/Cash flow per share--
Book value per share47.42
Tangible book value per share-5.65
More ▼

Balance sheet in USDView more

QuidelOrtho Corp has a Debt to Total Capital ratio of 44.46%, a lower figure than the previous year's 45.80%.
Current ratio1.38
Quick ratio0.8134
Total debt/total equity0.8003
Total debt/total capital0.4446
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items dropped -101.58%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		-14,532.81
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.